Mr. Live has over 15 years of various experience in finance and capital markets. Most recently, Mr. Live contributed to the growth of a structured finance program for one of the largest insurance and wealth management groups in Canada. Particularly, Mr. Live developed financial models for risk management and asset pricing.
Dr. Hayman is currently Vice-President of Research and Development at ChipCare, developers of a point-of-care platform that will bring lifesaving diagnostics to millions without access, specializes in biosensors and optical detection systems. He has in-depth expertise in assay development, analytical device development, biosafety and regulations. Dr. Hayman received a Ph.D. in Chemistry from Dr. David Walt lab at Tufts University in Boston.
Mr. Atkin is CEO of Gladius Pharmaceuticals, a biotechnology firm developing novel drugs to treat life-threatening, multi-drug-resistant bacterial infections. He has many years of experience in advancing early stage life sciences products and technologies towards commercialization. Mir. Atkin helped life sciences startups raise over $30 million in funding.
Mr. Chan has 18 years of industry experience electronics industry experience in medical devices and telecommunications. Specialized in RF/precision analog/EMI&EMC design, Mr Chan worked on more than a dozen cell phone designs and many patents at RIM headquarter in Waterloo. He now bring his many years of experience with large international business and innovative mindset to help startups accelerate product development and commercialization.
Mr. Masson is Director Software Research & Development for AV&R. In addition to his deep knowledge in machine vision and robotics, Mr Masson works with international clients to focus technological development according to clients’ needs.
For more information please email us